Drug-eluting fibers for HIV-1 inhibition and contraception
about
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsMulticompartmental pharmacokinetic model of tenofovir delivery by a vaginal gelCiprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureusA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Vaginal deployment and tenofovir delivery by microbicide gels"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gelsDelivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIVManufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation.Protease-degradable electrospun fibrous hydrogelsImaging single cells in a beam of live cyanobacteria with an X-ray laser.Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema.In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.Tunable Release of Multiclass Anti-HIV Drugs that are Water-Soluble and Loaded at High Drug Content in Polyester Blended Electrospun Fibers.Current strategies for sustaining drug release from electrospun nanofibers.Electrospun nanofibers-mediated on-demand drug release.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Beyond HIV microbicides: multipurpose prevention technology products.Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maravirocIn pursuit of functional electrospun materials for clinical applications in humans.Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Application of electrospun fibers for female reproductive health.On-demand microbicide products: design matters.Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.Harnessing nanostructured systems for improved treatment and prevention of HIV disease
P2860
Q28087336-7239A558-406F-4BB8-A1D8-C00CAB834331Q28533251-45BF48F6-ECF1-4F27-9984-F629BC5BFE98Q28545938-9A0B3FCC-EF68-4426-ADE4-6E3DB606377BQ30431343-50DEA25C-50C1-4DDA-8757-E2B25ED706C8Q30647900-5D029CD9-BCC9-4585-A8AA-8A282DDCD53EQ33601303-40496316-7446-41DF-8733-74BB72551C54Q33800752-36B69A2F-C39E-45CB-9600-02B36E107E52Q34058160-AD9A7A01-3399-4637-9D31-42EEF8681FF2Q34604290-09B1EFCD-1BD5-4B2F-9BE1-6FB4709E1004Q35174770-D774291A-98F8-43C7-85F1-0CCFD23AD6F0Q35213164-3130976D-8ACC-4208-A2AE-CF9EE0001D3FQ35559024-5A77092D-9AF7-4069-A917-50396C6F6121Q36257669-F35C11A3-4BAD-44AE-BBB9-1EE30F404633Q36630547-0756CEA4-32EA-451C-B6B0-D3727624DD6CQ37255082-F63124F4-36C3-4CC2-B29E-4AEAC6F44F0AQ37358616-63942ED9-DF0E-45D4-90E7-1F5B0648DCE6Q37565913-0EAB62FB-027C-4489-8D77-82E5178E0863Q37585816-51A5C9B8-72FC-4E12-9EF4-942B794F610EQ38217153-2075FB60-3A72-451B-B0CC-9EE8CE92F914Q38260862-ABB8DB23-CABA-4CDE-B502-D2866A6AE20AQ38261814-83FC1A23-8C72-42E0-99FF-9B672BB6FFAEQ38781199-E1C1B2B1-CC95-4B2F-BB23-7FFD1CC89759Q38850505-A99BB266-316E-4AB6-A86D-3FD8BAE00728Q39063908-4F09A9CC-D29B-4685-9232-B3FD43EE85ABQ39301728-9439BC0F-F372-4B68-A055-9F7631365FCAQ39356290-BC20F9E5-4C54-472C-B32C-F43449B90E6FQ40086722-8A2ADF92-D8FC-4E48-AC64-CF142823C106Q47384815-71B728C8-7EC7-4F36-84EA-D3EB75D341F5Q47930607-1BF6009B-DCBF-4CBA-94F3-58E29F07FF3FQ56992437-CB276D64-CC51-4FC0-A558-15763AE71DB2
P2860
Drug-eluting fibers for HIV-1 inhibition and contraception
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Drug-eluting fibers for HIV-1 inhibition and contraception
@ast
Drug-eluting fibers for HIV-1 inhibition and contraception
@en
Drug-eluting fibers for HIV-1 inhibition and contraception
@en-gb
Drug-eluting fibers for HIV-1 inhibition and contraception
@nl
type
label
Drug-eluting fibers for HIV-1 inhibition and contraception
@ast
Drug-eluting fibers for HIV-1 inhibition and contraception
@en
Drug-eluting fibers for HIV-1 inhibition and contraception
@en-gb
Drug-eluting fibers for HIV-1 inhibition and contraception
@nl
altLabel
Drug-Eluting Fibers for HIV-1 Inhibition and Contraception
@en
prefLabel
Drug-eluting fibers for HIV-1 inhibition and contraception
@ast
Drug-eluting fibers for HIV-1 inhibition and contraception
@en
Drug-eluting fibers for HIV-1 inhibition and contraception
@en-gb
Drug-eluting fibers for HIV-1 inhibition and contraception
@nl
P2093
P2860
P1433
P1476
Drug-eluting fibers for HIV-1 inhibition and contraception
@en
P2093
Cameron Ball
Emily Krogstad
Kim A Woodrow
Thanyanan Chaowanachan
P2860
P304
P356
10.1371/JOURNAL.PONE.0049792
P407
P577
2012-01-01T00:00:00Z